Larimar Therapeutics Inc (LRMR) Event May 12, 2022, 00:00 UTC (28% Negative) LARIMAR THERAPEUTICS, INC. (LRMR) Reports 36% Loss Increase for 2022-03-31 Full text
Register to leave comments News bot Oct. 29, 2025, 8:50 a.m. 🏢 Larimar Therapeutics Inc (LRMR) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-05-12 📊 Period of Report: 2022-03-31 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-12.10M $-8.90M $-3.20M -35.96% 📈 Total Assets $78.67M $71.22M $7.44M +10.45% 📈 Total Liabilities $14.25M $14.12M $136.00K +0.96% ↗️ Stockholders' Equity $78.78M $1.00K $78.78M +7878300.00% 📈 Operating Income/Loss $-12.11M $-8.89M $-3.22M -36.22% 📈 R&D Expense $100.00K $100.00K N/A +0.00% ➡️ Earningspersharebasic $-0.76 $-0.49 $-0.27 -55.10% 📉 Earningspersharediluted $-0.76 $-0.49 $-0.27 -55.10% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Larimar Therapeutics Inc (LRMR) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document